A Mouse Model to Test Novel Therapeutics for Parkinson’s Disease: an Update on the Thy1-aSyn (“line 61”) Mice

Development of neuroprotective therapeutics for Parkinson’s disease (PD) is facing a lack of translation from pre-clinical to clinical trials. One strategy for improvement is to increase predictive validity of pre-clinical studies by using extensively characterized animal models with a comprehensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Franziska, Stanojlovic, Milos, Käufer, Christopher, Gericke, Birthe, Feja, Malte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119371/
https://www.ncbi.nlm.nih.gov/pubmed/36715870
http://dx.doi.org/10.1007/s13311-022-01338-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119371/
https://www.ncbi.nlm.nih.gov/pubmed/36715870
http://dx.doi.org/10.1007/s13311-022-01338-0

Ejemplares similares